(Q39009691)

8 September 2017

Personalization of loco-regional care for primary breast cancer patients (part 2). (English)

1 reference

8 September 2017

1 reference

Alexey A Larionov

21

0 references

Chiun-Sheng Huang

object named as

Chiun-Sheng Huang

15

0 references

Dong-Young Noh

27

object named as

Dong Young Noh

1 reference

8 September 2017

16

Wonshik Han

1 reference

8 September 2017

10

Hironobu Sasano

1 reference

8 September 2017

4

Takashi Inamoto

1 reference

8 September 2017

1

Masakazu Toi

1 reference

8 September 2017

2

Eric P Winer

1 reference

8 September 2017

8

Stephen R Grobmyer

1 reference

8 September 2017

9

Ismail Jatoi

1 reference

8 September 2017

11

Ian Kunkler

1 reference

8 September 2017

13

Chikako Yamauchi

1 reference

8 September 2017

14

Louis W C Chow

1 reference

8 September 2017

17

Shinzaburo Noguchi

1 reference

8 September 2017

18

Mark D Pegram

1 reference

8 September 2017

19

Hideko Yamauchi

1 reference

8 September 2017

23

Michio Yoshimura

1 reference

8 September 2017

24

Tomoharu Sugie

1 reference

8 September 2017

25

Akira Yamauchi

1 reference

8 September 2017

26

Ian E Krop

1 reference

8 September 2017

28

V Suzanne Klimberg

1 reference

2014 Kyoto Breast Cancer Consensus Conference

8 September 2017

29

object named as

2014 Kyoto Breast Cancer Consensus Conference

1 reference

8 September 2017

3

John R Benson

1 reference

8 September 2017

6

Gunter von Minckwitz

1 reference

8 September 2017

John F Forbes

5

1 reference

8 September 2017

John F R Robertson

7

1 reference

8 September 2017

Alice Y Ho

12

1 reference

8 September 2017

Eun-Sook Lee

20

1 reference

8 September 2017

Jose L B Bevilacqua

22

1 reference

8 September 2017

language of work or name

English

0 references

publication date

1 January 2015

1 reference

8 September 2017

1 reference

8 September 2017

11

1 reference

8 September 2017

9

1 reference

8 September 2017

1301-1305

1 reference

Post-mastectomy radiotherapy for breast cancer patients with t1-t2 and 1-3 positive lymph nodes: a meta-analysis

8 September 2017

1 reference

Effect of radiotherapy after mastectomy and axillary surgery on 10-year recurrence and 20-year breast cancer mortality: meta-analysis of individual patient data for 8135 women in 22 randomised trials.

21 January 2018

1 reference

Locoregional radiotherapy in patients with breast cancer responding to neoadjuvant chemotherapy: a paradigm for treatment individualization

21 January 2018

1 reference

Predictors of locoregional recurrence after neoadjuvant chemotherapy: results from combined analysis of National Surgical Adjuvant Breast and Bowel Project B-18 and B-27.

21 January 2018

1 reference

Axillary dissection versus no axillary dissection in patients with sentinel-node micrometastases (IBCSG 23-01): a phase 3 randomised controlled trial

21 January 2018

1 reference

Radiotherapy or surgery of the axilla after a positive sentinel node in breast cancer (EORTC 10981-22023 AMAROS): a randomised, multicentre, open-label, phase 3 non-inferiority trial

21 January 2018

1 reference

Adjuvant radiotherapy of regional lymph nodes in breast cancer - a meta-analysis of randomized trials

21 January 2018

1 reference

Functional lymphatic anatomy for sentinel node biopsy in breast cancer: echoes from the past and the periareolar blue method

21 January 2018

1 reference

Personalizing the treatment of women with early breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2013

21 January 2018

1 reference

Pathological complete response and long-term clinical benefit in breast cancer: the CTNeoBC pooled analysis

21 January 2018

1 reference

Meta-analysis of agreement between MRI and pathologic breast tumour size after neoadjuvant chemotherapy

21 January 2018

1 reference

Presurgical (neoadjuvant) endocrine therapy is a useful model to predict response and outcome to endocrine treatment in breast cancer patients

21 January 2018

1 reference

Neoadjuvant anastrozole versus tamoxifen in patients receiving goserelin for premenopausal breast cancer (STAGE): a double-blind, randomised phase 3 trial

21 January 2018

1 reference

Evaluating the 21-gene assay Recurrence Score® as a predictor of clinical response to 24 weeks of neoadjuvant exemestane in estrogen receptor-positive breast cancer

21 January 2018

1 reference

Mechanisms of resistance to therapies targeting BRCA-mutant cancers

21 January 2018

1 reference

A simulation model to predict the impact of prophylactic surgery and screening on the life expectancy of BRCA1 and BRCA2 mutation carriers

21 January 2018

1 reference

Neoadjuvant and adjuvant trastuzumab in patients with HER2-positive locally advanced breast cancer (NOAH): follow-up of a randomised controlled superiority trial with a parallel HER2-negative cohort

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.2217/FON.15.66

1 reference

8 September 2017

1 reference